Vyvron Review
GLP-1 weight-loss telehealth · Independently scored 5.2/10
Best for: seeing what it charges before you answer any medical questions
Vyvron rates best on getting signed up and staying signed up.
then $179/mo ongoing
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Two membership tiers are on sale, $149 and $199 for each four-week period, both founding-member rates; they revert later to $179 and $249. The company states plainly that it is neither pharmacy nor medical practice, with pharmacy and clinical work running through OpenLoop Health plus the professional entities affiliated with it. Its LegitScript certification checks out, and the registration is Wyoming. Semaglutide and tirzepatide get named as possibilities, but no published price is ever attached to either.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Vyvron
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Vyvron at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $149/mo (Founding-member rate of $149 per 4 weeks is locked for the life of the membership; the standing rate is $179. Vyvron...)
- FDA status
- No FDA warning letter on record
How Vyvron scores
Six columns, each one computed from something Vyvron has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.0/10The figures published here are not comparable monthly cash prices for the medication — an insured copay, a per-vial rate, a membership fee or a starting-dose teaser. Capped rather than scored against the register.
Effectiveness25%
5.0/10The published price list names no GLP-1 we can match to a pivotal trial, so the medications on offer cannot be scored on evidence.
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Vyvron
Last checked August 2026- Re-read the price on file across 2 dose or plan tiers
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Vyvron involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Vyvron publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Vyvron does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- No comparable monthly cash price for the medication is on record — either nothing is published, or what is published is a fee, an insured copay or a per-vial rate rather than a monthly cost.
- No state list is published, so whether Vyvron serves your state cannot be confirmed from its site.
Pricing
Prices re-verified
Founding-member rate of $149 per 4 weeks is locked for the life of the membership; the standing rate is $179. Vyvron does not state which medication this tier buys.
Founding-member rate of $199 per 4 weeks is locked for the life of the membership; the standing rate is $249. Vyvron does not state which medication this tier buys.
Check the price yourself before you pay
Every figure here was read off Vyvron's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
What Vyvron charges
Vyvron advertises $149. That buys the first month. The standing rate is $179/month, and that is the one worth doing arithmetic on, because the introductory figure applies once.
- Lower tier, billed every 4 weeks (13 charges a year, not 12) — $149 first month, then $179/month
- Higher tier, billed every 4 weeks (13 charges a year, not 12) — $199 first month, then $249/month
The median across the GLP-1 providers we track is about $169/month, so this lands mid-market — close enough that the deciding factor is unlikely to be price.
What we could verify
Vyvron publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will be paying in month three.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
Our read
Vyvron is a cheap way to start and an ordinary way to continue. Use the $149 month for what it is good for — establishing whether the medication works for you — and re-run the numbers against $179/month before you let it renew twice.
The Bottom Line
Vyvron rates best on getting signed up and staying signed up.
Before you pay Vyvron
Starting at $149/month. Check today's price, then book the free consultation.
Where Vyvron is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Vyvron review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See Vyvron's current pricing
Plans start at $149/month. The free consultation is where you learn whether you qualify, and what it costs today.